Bipolar disorder is a mental health condition that causes significant and sudden changes in mood that involve episodes of mania and sometimes depression. There is no cure for bipolar disorder, so ...

Dr. Calabrese answers the question: 'When Can I Stop Taking Bipolar Meds?' — -- Question: How long do I have to take medication for bipolar disorder, and can I stop if I no longer have symptoms?

Each month, The Clinical Advisor makes one new clinical feature available ahead of print. Don’t forget to take the poll. The results will be published in the next month’s issue. Bipolar disorder is a ...

The FDA has approved Caplyta as adjunctive therapy with antidepressants to treat major depressive disorder in adults, ...

Results from the largest and longest study of its kind have found that the drug metformin can help manage weight gain in ...

Bipolar disorder is a long-term mood disorder characterized by major fluctuations in mood — both high and low — that can impact daily functioning and behavior. Although bipolar disorder is a chronic ...

Medically reviewed by Mary Choy, PharmDMedically reviewed by Mary Choy, PharmD Trileptal (oxcarbazepine) is an anticonvulsant drug approved by the U.S. Food and Drug Administration (FDA) to treat ...

When Natasha Tracy was 19, a psychiatrist diagnosed her with minor depression. “I knew this was wrong,” Tracy says. “He hadn’t listened to me. I was suffering from severe, suicidal depression.” In ...

Most psychotherapy, whether short-term problem focused or long-term psychoanalytically-oriented treatment, relies upon a dialogue between the therapist and the patient. The purpose of this dialogue is ...

As a premier non-profit behavioral health system, our residential program for boys and girls, ages 6-17, treats a wide range of mental health disorders. We also offer a dual diagnosis program for ...

Hayes et al 12 conducted one of the most recent large studies to compare lithium with newer second-generation antipsychotics as maintenance monotherapy for bipolar disorder. The authors concluded that ...

The U.S. Food and Drug Administration has approved Caplyta (lumateperone) as an adjunctive therapy with antidepressants for ...